Skip to Content

Tag: glucose sensor


News

In brief: PAP recall, indie outlook, OTC sensor, Kalogon hire

October 6, 2026HME News Staff

WASHINGTON – BMC Medical retrospectively reported to the U.S. Food and Drug Administration (FDA) a recall of 20,160 Luna G3 APAP devices (model LG3600) distributed in the United States due to a firmware defect, the agency has reported. The FDA has classified it as a Class I recall (FDA Recall Number: Z-2979-2026). BMC has identified that the firmware version G3-2.00.76 with configuration G3 A20-31.cfg that is installed on these Luna devices contained a debug code. The company conducted...

Complex Rehab Technology (CRT), CPAP, Diabetes, Food & Drug Administration (FDA), glucose sensor, Kalogon, National Community Pharmacists Association (NCPA), Recall


Read Full Articlered right arrow icon

Also Noted

Biolinq glucose sensor receives clearance for OTC use

October 5, 2026HME News Staff

SAN DIEGO – Biolinq Incorporated has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for over-the-counter (OTC) use of Biolinq Shine, the company’s needle-free glucose sensor designed to provide a simple, intuitive view of glucose, activity and sleep information in a single device with autonomous operation. The clearance expands access to Biolinq Shine without a prescription, marking the company’s latest regulatory milestone following FDA...

510(k) clearance, Biolinq, Biolinq Shine, Diabetes, Food & Drug Administration (FDA), glucose sensor, Over the counter


Read Full Articlered right arrow icon